ContractClinical Trial Agreement • July 25th, 2019
Contract Type FiledJuly 25th, 2019AMENDMENT # 1toCLINICAL TRIAL AGREEMENT 008/OVZ/17/029-P DODATEK č. 1keSMLOUVĚ O KLINICKÉM HODNOCENÍ 008/OVZ/17/029-P This is Amendment # 1 to Clinical Trial Agreement (the “Amendment”) made effective as of the date of publishing this Amendment according to the Act No. 340/2015 Coll., on Register of Contracts (“Amendment Effective Date”) by and among Syneos Health UK Limited, located at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire GU14 7BF, United Kingdom (“CRO”), acting in its own name and for and on behalf of and in the name of Incyte Corporation, located at 1801 Augustine Cut-Off, Wilmington, DE 19803, USA (“Sponsor”), Fakultni nemocnice Ostrava, located at17. listopadu 1790/5, 708 52 Ostrava – Poruba, Czech Republic, ID No.: 00843989, VAT No.: CZ00843989, in matters related to this Amendment represented by: doc. MUDr. Petr Vávra, Ph.D., Deputy Director for Science and Research (“Institution”), and prof. MUDr. Roman Hajek, CSc., having his place of work at